An interventional study of Thoracic High Velocity, Low Amplitude Thrust Maneuver (HVLATM) and Scapular High Velocity, Low Amplitude Thrust Maneuver in Shoulder Impingement, sponsored by UConn Health. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years. Per ClinicalTrials.gov, last updated 2017-04-26.
Sponsored by UConn Health · Not applicable, Interventional, and Treatment
Shoulder impingement has been identified as the most common cause of shoulder pain in the adult general population. Sometimes therapeutic pushing on the middle part of the back (manual therapy) decreases shoulder pain in someone experiencing shoulder impingement. We do not known what causes the decreased shoulder pain. It could be that the therapeutic pushing makes things move better. It may be that the person getting their back treatment thinks they are better or the physical therapist who provides the manual treatment thinks it works.
Shoulder impingement has been identified as the most common cause of shoulder pain in the adult general population. High-Velocity, Low-Amplitude Thrust Manipulations (HVLATM) of the thoracic spine and ribs result in increased shoulder ROM, as well as decreased pain and disability in patients suffering shoulder impingement. The quality of the sparse publications is low and lacking control or comparison groups regarding the use of HVLATM in the management of shoulder impingement. Further higher quality randomized clinical trials are needed. Moreover, no research has investigated the effects of the patients beliefs and different types of verbal messages conveyed by the clinician to the subjects in regard to the effects of HVLATM of the thoracic spine on shoulder pain and function. The purpose of this study is to evaluate, in subjects with signs and symptoms of shoulder impingement: (1) the effects of a series of the prone thoracic spine High Velocity Low Amplitude Thrust Manipulation (HVLATM) as compared to the HVLATM directed at the scapula, on shoulder pain, impingement symptoms, and functional outcomes; (2) the effect of the type of message and language used by the clinician in regard to thoracic HVLATM on shoulder pain, impingement symptoms, and functional outcomes; (3) the effect of subject's expectation of outcome of thoracic and scapula HVLATM on shoulder pain, impingement symptoms, and functional outcomes; (4) if these potential immediate improvements will be sustained at 6 to 9-day follow up.
312 studies on the registry are indexed under Shoulder Impingement Syndrome; 58 are open to participants now.
This study's enrollment of 97 is above the median of 54 across 267 interventional studies indexed under Shoulder Impingement Syndrome.
Browse Shoulder Impingement Syndrome studies →UConn Health is the lead sponsor of 187 studies on the registry; 18 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 7 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Thoracic HVLAMT with a positive message given prior to the intervention.
Other: Thoracic High Velocity, Low Amplitude Thrust Maneuver (HVLATM)
Thoracic HVLAMT with a neutral message given prior to the intervention.
Other: Thoracic High Velocity, Low Amplitude Thrust Maneuver (HVLATM)
Scapular HVLAMT with a positive message given prior to the intervention.
Other: Scapular High Velocity, Low Amplitude Thrust Maneuver
Scapular HVLAMT with a neutral message given prior to the intervention.
Other: Scapular High Velocity, Low Amplitude Thrust Maneuver
Shoulder Pain and Disability Index (SPADI)
The primary outcome measure is SPADI score at 6-9 days post intervention. The SPADI is also collected pretreatment and immediately post treatment.
Time frame: 6-9 days following treatment
Numeric Pain Rating Scale
Time frame: Pre, Post, and 6-9 days following treatment
5 point Likert scale to asses effects of messaging (positive vs. neutral)
Time frame: Pre-intervention
This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shoulder Impingement Syndrome →